A novel peptide-based tau aggregation inhibitor as a potential therapeutic for Alzheimer's disease and other tauopathies. - Aggidis A; Devitt G; Zhang Y; Chatterjee S; Townsend D; Fullwood NJ; Ortega ER; Tarutani A; Hasegawa M; Cooper A; Williamson P; Mendoza-Oliva A; et al. (Alzheimer's & dementia : the journal of the Alzheimer's Association, 2024)